Publication:
Methicillin-resistant Staphylococcus aureus in Nepal

Simple item page
creativeworkseries.issnJNMA Print ISSN: 0028-2715; Online ISSN: 1815-672X
dc.contributor.authorShrestha, Lok Bahadur
dc.contributor.authorSyangtan, Gopiram
dc.contributor.authorBasnet, Ajaya
dc.contributor.authorAcharya, Krishna Prasad
dc.contributor.authorChand, Arun Bahadur
dc.contributor.authorPokhrel, Khilasa
dc.date.accessioned2026-03-10T07:37:29Z
dc.date.available2026-03-10T07:37:29Z
dc.date.issued2021
dc.descriptionLok Bahadur Shrestha School of Medical Sciences and The Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia https://orcid.org/0000-0002-0054-0715 Gopiram Syangtan Tribhuvan University, Shi-Gan International College of Science and Technology, Kathmandu, Nepal Ajaya Basnet Tribhuvan University, Shi-Gan International College of Science and Technology, Kathmandu, Nepal Krishna Prasad Acharya Animal Quarantine Office, Budhanilkantha, Kathmandu, Nepal Arun Bahadur Chand Department of Clinical Laboratory, Kist Medical College & Teaching Hospital, Kathmandu, Nepal Khilasa Pokhrel Department of Microbiology, Kathmandu Medical College, Sinamangal, Kathmandu, Nepal
dc.description.abstractAbstract: Staphylococcus aureus is both a frequent commensal and a leading cause of endocarditis, bacteremia, osteomyelitis and skin and soft tissue infections and device-related infections. We performed this minireview to summarize the prevalence of Staphylococcus aureus among clinical samples and estimate the proportion of methicillin-resistant Staphylococcus aureus. The prevalence of Staphylococcus aureus among clinical isolates in Nepal is 34.5%. On average, the proportion of multi-drug resistance in Staphylococcus aureus is 57.1%. Methicillin-resistant Staphylococcus aureus accounts for a total of 41.7%. Inducible clindamycin resistance was detected in about 35% of the isolates. A regular antimicrobial resistance surveillance mechanism is necessary to mitigate the development of resistance among organisms and further spread of superbugs like methicillin-resistance Staphylococcus aureus.
dc.identifierhttps://doi.org/10.31729/jnma.6251
dc.identifier.urihttps://hdl.handle.net/20.500.14572/5010
dc.language.isoen_US
dc.publisherNepal Medical Association
dc.subjectclindamycin
dc.subjectmethicillin-resistant Staphylococcus aureus
dc.subjectmulti drug resistance
dc.titleMethicillin-resistant Staphylococcus aureus in Nepal
dc.typeArticle
dspace.entity.typePublication
local.article.typeReview Article
oaire.citation.endPage522
oaire.citation.startPage518
relation.isJournalIssueOfPublicationf91c66a1-3b0d-48a3-8442-48b02fba5745
relation.isJournalIssueOfPublication.latestForDiscoveryf91c66a1-3b0d-48a3-8442-48b02fba5745
relation.isJournalOfPublicatione6e146a0-0ece-4aba-aa0a-6ccfbd10a12a

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
518-522.pdf
Size:
304.37 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.86 KB
Format:
Item-specific license agreed to upon submission
Description:
Download

Collections

Publications

Connect with us

Nepal Health Research Council © 2026
Ramshah Path, Kathmandu Nepal P.O.Box 7626